Have a personal or library account? Click to login
Characterization of Liver Metastases During Catheter-Directed Liver Interventions: A Comparison between Dual Phase Cone-Beam Computed Tomography and Conventional Contrast-Enhanced Computed Tomography Cover

Characterization of Liver Metastases During Catheter-Directed Liver Interventions: A Comparison between Dual Phase Cone-Beam Computed Tomography and Conventional Contrast-Enhanced Computed Tomography

Journal of the Belgian Society of Radiology
Volume 104 (2020): Issue 1
By: Geert Maleux,  Maria-Louisa Izamis,  Cedric Werbrouck,  Alessandro Radaelli,  Hans Prenen,  Eric Van Cutsem and  Vincent Vandecaveye  
Open Access
|Jul 2020

References

  1. 1Prenen H, Van Cutsem E. Oncological management of unresectable liver metastases. Dig Dis. 2012; 30: 137–142. DOI: 10.1159/000342047
    Back to article
  2. 2Gruenberger T, Beets G, Van Laethem J, et al. Treatment sequence of synchronously (liver) metastasized colon cancer. Dig Liver Dis. 2016; 48: 1119–1123. DOI: 10.1016/j.dld.2016.06.009
    Back to article
  3. 3Bonne L, Verslype C, Laenen A, et al. Safety and efficacy of doxorubicin-eluting superabsorbent polymer microspheres for the treatment of liver metastases from neuroendocrine tumors: Preliminary results. Radiol Oncol. 2017; 51: 74–80. DOI: 10.1515/raon-2017-0007
    Back to article
  4. 4Kolbeck K, Farsad K. Catheter-based treatments for hepatic metastases from neuroendocrine tumors. AJR Am J Roentgenol. 2014; 203: 717–724. DOI: 10.2214/AJR.14.12983
    Back to article
  5. 5Maes T, Wildiers H, Heye S, et al. Intrahepatic Mitomycin C bolus infusion in the treatment of extensive liver metastases of breast cancer. Breast Cancer Res Treat. 2008; 110: 135–142. DOI: 10.1007/s10549-007-9707-4
    Back to article
  6. 6Vogl T, Koch S, Lotz G, et al. Percutaneous isolated hepatic perfusion as a treatment for isolated hepatic metastases of uveal melanoma: Patient outcome and safety in a multi-centre study. Cardiovasc Intervent Radiol. 2017; 40: 864–872. DOI: 10.1007/s00270-017-1588-2
    Back to article
  7. 7Maleux G, Deroose C, Laenen A, et al. Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survival. Acta Oncol. 2016; 55: 486–495. DOI: 10.3109/0284186X.2015.1101151
    Back to article
  8. 8Ronot M, Clift A, Vilgrain V, Frilling A. Functional imaging in liver tumours. J Hepatol. 2016; 65: 1017–1030. DOI: 10.1016/j.jhep.2016.06.024
    Back to article
  9. 9Tirumani S, Kim K, Nishino M, et al. Update on the role of imaging in management of metastatic colorectal cancer. Radiographics. 2014; 34: 1908–1928. DOI: 10.1148/rg.347130090
    Back to article
  10. 10Pung L, Ahmad M, Mueller K, et al. The role of cone-beam CT in transcatheter arterial chemoembolization for hepatocellular carcinoma: A systematic review and meta-analysis. J Vasc Interv Radiol. 2017; 28: 334–341. DOI: 10.1016/j.jvir.2016.11.037
    Back to article
  11. 11Tacher V, Radaelli A, Lin M, Geschwind J. How I do it: Cone-beam CT during transarterial chemoembolization for liver cancer. Radiology. 2015; 274: 320–334. DOI: 10.1148/radiol.14131925
    Back to article
  12. 12Tanaka T, Arai Y, Inaba Y, et al. Current role of hybrid CT/angiography system compared with C-arm cone beam CT for interventional oncology. Br J Radiol. 2014; 87: 20140126. DOI: 10.1259/bjr.20140126
    Back to article
  13. 13Bapst B, Lagadec M, Breguet R, Vilgrain V, Ronot M. Cone beam computed tomography (CBCT) in the field of interventional oncology of the liver. Cardiovasc Intervent Radiol. 2016; 39: 8–20. DOI: 10.1007/s00270-015-1180-6
    Back to article
  14. 14Deschamps F, Solomon S, Thornton R, et al. Computed analysis of three-dimensional cone-beam computed tomography angiography for determination of tumor-feeding vessels during chemoembolization of liver tumor: A pilot study. Cardiovasc Intervent Radiol. 2010; 33: 1235–1242. DOI: 10.1007/s00270-010-9846-6
    Back to article
  15. 15Iwazawa J, Ohue S, Hashimoto N, Abe H, Hamuro M, Mitani T. Detection of hepatocellular carcinoma: Comparison of angiographic C-arm CT and MDCT. AJR Am J Roentgenol. 2010; 195: 882–887. DOI: 10.2214/AJR.10.4417
    Back to article
  16. 16Iwazawa J, Ohue S, Hashimoto N, Muramoto O, Mitani T. Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma. Eur J Radiol. 2012; 81: 3985–3992. DOI: 10.1016/j.ejrad.2012.08.012
    Back to article
  17. 17Higashihara H, Osuga K, Onishi H, et al. Diagnostic accuracy of C-arm CT during selective transcatheter angiography for hepatocellular carcinoma: Comparison with intravenous contrast-enhanced, biphasic, dynamic MDCT. Eur Radiol. 2012; 22: 872–879. DOI: 10.1007/s00330-011-2324-y
    Back to article
  18. 18Loffroy R, Lin M, Rao P, et al. Comparing the detectability of hepatocellular carcinoma by C-arm dual phase cone-beam computed tomography during hepatic arteriography with conventional contrast-enhanced magnetic resonance imaging. Cardiovasc Intervent Radiol. 2012; 35: 97–104. DOI: 10.1007/s00270-011-0118-x
    Back to article
  19. 19Loffroy R, Lin M, Yenokyan G, et al. Intraprocedural C-arm dual phase cone beam CT: Can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma? Radiology. 2013; 266: 636–648. DOI: 10.1148/radiol.12112316
    Back to article
  20. 20Miyayama S, Yamashiro M, Okuda M, et al. Detection of corona enhancement of hypervascular hepatocellular carcinoma by C-arm dual phase cone-beam CT during hepatic arteriography. Cardiovasc Intervent Radiol. 2011; 34: 81–86. DOI: 10.1007/s00270-010-9835-9
    Back to article
  21. 21Meyer B, Frericks B, Voges M, et al. Visualization of hypervascular liver lesions during TACE: Comparison of angiographic C-arm CT and MDCT. AJR Am J Roentgenol. 2008; 190: 263–269. DOI: 10.2214/AJR.07.2695
    Back to article
  22. 22Schernthaner R, Haroun R, Duran R, et al. Improved visibility of metastatic disease in the liver during intra-arterial therapy using delayed arterial phase cone-beam CT. Cardiovasc Intervent Radiol. 2016; 39: 1429–1437. DOI: 10.1007/s00270-016-1406-2
    Back to article
  23. 23Ulrich G, Dudeck O, Furth C, et al. Predictive value of intratumoral 99m Tc-macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres. J Nucl Med. 2013; 54: 516–522. DOI: 10.2967/jnumed.112.112508
    Back to article
  24. 24Louie J, Kothary N, Kuo W, et al. Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization. J Vasc Interv Radiol. 2009; 20: 606–613. DOI: 10.1016/j.jvir.2009.01.021
    Back to article
  25. 25Bernardini M, Smadja C, Faraggi M, et al. Liver selective internal radiation therapy with 90Y resin microspheres: Comparison between pre-treatment activity calculation methods. Phys Med. 2017; 30: 752–764. DOI: 10.1016/j.ejmp.2014.05.004
    Back to article
DOI: https://doi.org/10.5334/jbsr.2052 | Journal eISSN: 2514-8281
Journal RSS Feed
Language: English
Submitted on: Jan 20, 2020
Accepted on: Jun 16, 2020
Published on: Jul 8, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
cone beam computed tomography,
diagnostic efficacy,
liver,
metastases,
radioembolization

© 2020 Geert Maleux, Maria-Louisa Izamis, Cedric Werbrouck, Alessandro Radaelli, Hans Prenen, Eric Van Cutsem, Vincent Vandecaveye, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 104 (2020): Issue 1Next article